Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGelion Regulatory News (GELN)

Share Price Information for Gelion (GELN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.00
Bid: 17.00
Ask: 19.00
Change: 0.00 (0.00%)
Spread: 2.00 (11.765%)
Open: 18.00
High: 18.00
Low: 18.00
Prev. Close: 18.00
GELN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Expanded Li-S R&D Facility launched

11 Oct 2023 07:00

RNS Number : 7632P
Gelion PLC
11 October 2023

REACH

11 October 2023

Gelion plc

("Gelion" or the "Company" or the "Group")

Expanded Li-S R&D Facility launched to enable prototyping toward commercial cell development

Gelion (AIM: GELN), the Anglo-Australian battery innovator, announces new Lithium-Sulfur (Li-S) Research and Development (R&D) Facility designed to optimise development and accelerate market readiness of this technology by producing more advanced cell prototypes.

Based in Sydney, adjacent to Gelion's research and corporate office, the facility will allow the Company to advance prototyping toward cell development and to capitalise on the combination of Gelion's existing technologies with the intellectual property (IP) packages acquired from Johnson Matthey in March 2023.

Having achieved technical progress with sulfur cathode chemistry, this facility will enable Gelion to build multi-layer pouch cells (a soft battery design where battery components are enclosed in a pouch casing, like in a mobile phone or laptop), which are the industry standard for testing batteries and the form factor used for customer off-take.

The new facility is another milestone as Gelion continues to deliver against its go-to-market strategy and will bring a multitude of benefits to the Group, including:

·

enabling researchers to more rapidly test promising research in multi-layer pouch cells;

·

enabling Gelion to effectively participate in joint development agreements with anode developers; and

·

enable the production of prototypes that can be supplied for preliminary third-party validation and safety testing.

The prototypes produced will be multi-layer pouch cells and further focused product development ahead of offtake with partners. The prototypes will also inform TRL 4 (Technology Readiness Levels) and are a key commercial proof point for Gelion's technology. The facility and its output will help underpin the winning of contracts and subsequent scale up to commercial manufacture.

Commenting on the new facility, John Wood, CEO said:

"The site has the capability to increase Gelion's prototyping toward cell development and the progressive commissioning of the capability commenced in late September 2023. The opening of this facility further evidences the steady progress Gelion is making on its path to commercialisation. We are incredibly excited to be opening this research and development facility to increase capacity to ensure we optimise development of Lithium Sulfur for the rapidly expanding market.

"Lithium-Sulfur is the next generation for electric mobility and has the potential to power the future of transport. Gelion has built a large IP moat, and, with its highly skilled team of specialists, we are working towards our goal of delivering commercially viable and scalable, next generation battery chemistries."

CONTACTS

Gelion plc

John Wood, CEO

Amit Gupta, CFO

Thomas Maschmeyer, Founder and Principal Technology Advisor

via Alma PR

Cavendish Capital Markets Limited (Nominated Adviser and Sole Broker)

+44 207 220 0500

Corporate Finance

Neil McDonald

Seamus Fricker

Fergus Sullivan

ECM

Barney Hayward

Alma PR (Financial PR Adviser)

Justine James

Hannah Campbell

Will Ellis Hancock

+44 20 3405 0205

gelion@almapr.co.uk

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NRAGUBDGRXBDGXB
12
Date   Source Headline
24th Apr 20248:30 amRNSMello Investor Presentation
4th Apr 20247:00 amRNSLi-S Cell High Energy Density Milestone Achieved
27th Mar 20247:00 amRNSInterim results to 31 December 2023
20th Mar 202410:09 amRNSNotice of Results and Investor Presentation
19th Mar 20247:00 amRNSLithium-Sulfur Battery development update
5th Feb 20247:00 amRNSSenior Leadership Team Appointments
29th Jan 20247:00 amRNSBlock Admission Return
16th Jan 202411:27 amRNSResult of General Meeting
22nd Dec 202310:41 amRNSExercise of Options, Director Shareholding & TVRs
21st Dec 202312:23 pmRNSResult of AGM
14th Dec 20234:15 pmRNSPosting of Annual Report and Notice of GM
13th Dec 20237:00 amRNSDirector/PDMR Shareholding - Grant of options
12th Dec 202312:00 pmRNSFinal results to 30 June 2023
1st Dec 20237:00 amRNSDirector/PDMR Dealings and Total Voting Rights
30th Nov 202312:40 pmRNSHolding(s) in Company
29th Nov 20237:00 amRNSNotice of Results and AGM
27th Nov 20234:54 pmRNSResult of GM and Total Voting Rights
23rd Nov 20237:01 amRNSNotice of Investor Presentation
23rd Nov 20237:00 amRNSResult of Retail Offer and Total Voting Rights
21st Nov 20237:00 amRNSGelion and Ionblox JDA signed
9th Nov 20231:00 pmRNSResult of Placing and Posting of Circular
9th Nov 20238:00 amRNSUK Retail Offer
9th Nov 20237:17 amRNSProposed Acquisition, Placing, Retail Offer and GM
11th Oct 20237:00 amRNSExpanded Li-S R&D Facility launched
15th Aug 20237:00 amRNSTrading update and two new agreements signed
27th Jul 20239:45 amRNSBlock Admission Return
6th Jul 20237:00 amRNSZinc battery solution and Lithium Sulfur update
5th Jul 20237:00 amRNSChange of Registered Office
1st Jun 202312:05 pmRNSDirector/PDMR Shareholding
31st May 202312:15 pmRNSDirector/PDMR Shareholding
25th May 20237:19 amRNSStrategic progress on Johnson Matthey IP acq
31st Mar 20237:00 amRNSTotal Voting Rights
28th Mar 20239:15 amRNSDirector/PDMR Shareholding
17th Mar 202310:45 amRNSDirector/PDMR Shareholding
16th Mar 20237:00 amRNSInterim results to 31 December 2022
13th Mar 20237:00 amRNSLithium Sulfur IP Acq + Innovation Challenge
9th Mar 20237:00 amRNSAcq. of Johnson Matthey’s battery IP portfolio
1st Mar 20238:17 amRNSTotal Voting Rights
24th Feb 20237:00 amRNSNotice of Results and Investor Presentation
27th Jan 20237:00 amRNSBlock Admission Return
16th Dec 202212:00 pmRNSDirector/PDMR Shareholding
12th Dec 20227:00 amRNSCEO Board Appointment and Grant of Options
9th Dec 202211:29 amRNSResult of AGM
6th Dec 20229:30 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSProof of performance additive viability
30th Nov 20229:50 amRNSDirector/PDMR Shareholding - Grant of options
24th Nov 202211:00 amRNSDirector/PDMR Shareholding
18th Nov 20229:00 amRNSDirector/PDMR Shareholding
15th Nov 20227:00 amRNSPosting of Annual Report and Notice of AGM
9th Nov 20227:01 amRNSFinal results to 30 June 2022
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.